Pharmacologic Inhibitors of MKK1 and MKK2
- 1 January 2001
- book chapter
- Published by Elsevier
- Vol. 332, 417-431
- https://doi.org/10.1016/s0076-6879(01)32219-x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The development and therapeutic potential of protein kinase inhibitorsCurrent Opinion in Chemical Biology, 1999
- Cross-cascade activation of ERKs and ternary complex factors by Rho family proteinsThe EMBO Journal, 1997
- Control of Thrombopoietin-Induced Megakaryocytic Differentiation by the Mitogen-Activated Protein Kinase PathwayMolecular and Cellular Biology, 1997
- Megakaryocytic Differentiation Induced by Constitutive Activation of Mitogen-Activated Protein Kinase KinaseMolecular and Cellular Biology, 1997
- Phosphatidylinositol 3-OH Kinase Activity Is Not Required for Activation of Mitogen-activated Protein Kinase by CytokinesPublished by Elsevier ,1996
- Interdependent Domains Controlling the Enzymatic Activity of Mitogen-Activated Protein Kinase Kinase 1Biochemistry, 1996
- PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in VivoJournal of Biological Chemistry, 1995
- Evidence for Multiple Activators for Stress-activated Protein Kinases/c-Jun Amino-terminal Kinases.Published by Elsevier ,1995
- [29] Assay and expression of mitogen-activated protein kinase, MAP kinase kinase, and RafPublished by Elsevier ,1995
- Identification of multiple extracellular signal-regulated kinases (ERKs) with antipeptide antibodies.Cell Regulation, 1991